Thiotriazoline eye drops 10 mg/ml bottle 5 ml

Instructions Thiotriazoline eye drops 10 mg/ml bottle 5 ml

Composition

active ingredient: thiotriazolin;

1 ml of solution contains thiotriazoline in terms of 100% substance 10 mg; 1 ml of solution contains 20 drops;

excipients: sodium chloride, methylcellulose, purified water.

Dosage form

Eye drops.

Main physicochemical properties: slightly opalescent, colorless or with a slightly yellowish tinge liquid.

Pharmacotherapeutic group

Ophthalmic drugs. ATX code S01X A.

Pharmacological properties

Pharmacodynamics

The pharmacological effect of thiotriazoline is due to the activation of the antioxidant enzyme system and inhibition of lipid peroxidation processes in ischemic areas of eye tissues, reducing the severity of neurotrophic disorders, increasing the intensity and speed of reparative processes, reducing the inflammatory reaction of tissues, improving blood flow in the microcirculatory bed of the eye. The drug promotes early restoration of corneal sensitivity, the formation of more gentle opacity, a significant reduction in the number of various complications, reduces the manifestations of visual asthenopia, improves the functional indicators of the accommodative muscle and central parts of the retina, which improves the functional ability of the eyes.

Pharmacokinetics

Not researched.

Indication

Injuries and burns of the eyeball, inflammatory dystrophic diseases of the cornea, viral conjunctivitis. For the prevention of eye inflammation, reducing the manifestation of visual asthenopia in people who work with personal computers.

Contraindication

Hypersensitivity to the drug.

Interaction with other medicinal products and other types of interactions

Unknown.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Use during pregnancy or breastfeeding

There are no contraindications.

Method of administration and doses

The drug is prescribed from the first days of the disease in the form of instillation of 2 drops 3–4 times a day into the conjunctival sac of the affected eye.

In severe lesions, it is recommended to combine instillations with subconjunctival or parabulbar injections of 0.5 ml of 1% solution once a day for 7–12 days. Instillations of Thiotriazolin are carried out for 14–15 days. If necessary, the course of treatment can be extended to 30 days.

For people who work at personal computers, the drug is prescribed in the form of instillations of 2 drops immediately before starting work, and then every 2 hours. The duration of use is determined individually by the doctor.

Due to the fact that after opening the vial, the drug is stored at a temperature of 4–8 °C, it must be warmed to room temperature before use.

Children

There is no experience with use in children, therefore it is not recommended to prescribe the drug to this age group of patients.

Overdose

If the recommended doses are followed, overdose is impossible.

Adverse reactions

The drug is usually well tolerated, reactions at the injection site are possible. With increased individual sensitivity, allergic reactions are possible, including itching, hyperemia. Cases of rhinitis have been reported.

Expiration date

4 years. Shelf life of the solution after opening the bottle is 5 days at a temperature of 4 °C to 8 °C.

Storage conditions

Store at a temperature not exceeding 25 °C in the original packaging.

Keep out of reach of children.

Packaging

5 ml in a bottle, 1 bottle with a dropper cap in a pack.

Vacation category

According to the recipe.

Producer

Limited Liability Company "Research Plant "GNTSLS".

Limited Liability Company "PHARMEX GROUP".

Location of the manufacturer and its business address

Ukraine, 61057, Kharkiv region, Kharkiv city, Vorobyovy street, building 8.

(Limited Liability Company "Research Plant "GNTSLS")

Ukraine, 08301, Kyiv region, Boryspil city, Shevchenko st., building 100.

(Limited Liability Company "PHARMEX GROUP")